货号	规格	价格	上海	北京	珠海	重庆	武汉
S80044-1mg促销	≥96%	￥142.00 ￥128.00 S80044-1mg ￥128.00 现货	10 10	-	-	-	-
S80044-5mg促销	≥96%	￥500.00 ￥450.00 S80044-5mg ￥450.00 现货	10 10	-	-	-	-
S80044-10mg促销	≥96%	￥800.00 ￥720.00 S80044-10mg ￥720.00 现货	10 10	-	-	-	-
S80044-25mg促销	≥96%	￥1600.00 ￥1440.00 S80044-25mg ￥1440.00 现货	4 4	-	-	-	-
S80044-50mg促销	≥96%	￥2720.00 ￥2450.00 S80044-50mg ￥2450.00 现货	3 3	-	-	-	-
S80044-100mg促销	≥96%	￥4630.00 ￥4170.00 S80044-100mg ￥4170.00 现货	1 1	-	-	-	-

大包装询价收藏产品

加入购物车

产品描述：

TAK-733 is a potent and selective MEK allosteric site inhibitor with an IC50 of 3.2 nM.

靶点：

MEK:3.2 nM (IC50);MEK

体内研究：

The pharmacokinetics of TAK-733 is evaluated in nude mouse, rat, dog and monkey. Low clearance and high oral bioavailability are observed in all species. TAK-733 demonstrates broad antitumor activity in mouse xenograft models of human cancer including models of melanoma, colorectal, NSCLC, pancreatic and breast cancer. Daily oral administration of 1, 3, 10, and 30 mg/kg of TAK-733 for 14 days (Days 10 to 23) results in tumor growth delay in the A375 cell-implanted mice (5/group). TAK-733 (35, 70, 100, and 160 mg/kg) also significantly inhibits tumor growth on an intermittent dosing schedule of 3 days per week for 2 weeks (Days 10, 13, 15, 17, 20, and 22). Three partial regressions (PR), a 60% response rate, are observed in mice administered with 30 mg/kg of TAK-733 daily and in mice administered with 160 mg/kg of TAK-733 intermittently. Responses, CR (complete regression) and partial regressions (PR) are also observed in mice administered with 70, 100, and 160 mg/kg of TAK-733 intermittently. The tumor regression rate is more pronounced with the intermittent administration regimen; the greatest reduction in tumor volume is observed at 160 mg/kg (57.29%), versus a maximum reduction of 46.97% at 30 mg/kg once daily. By the last day of administration, tumor growth is significantly (p<0.05 for %T/C, Student's t-test) inhibited in mice administered 3, 10, and 30 mg/kg once daily or 35, 70, 100, and 160 mg/kg intermittently

参考文献：

1. Dong Q, et al. Discovery of TAK-733, a potent and selective MEK allosteric site inhibitor for the treatment of cancer. Bioorg Med Chem Lett. 2011 Mar 1;21(5):1315-9. 2. Micel LN, et al. Antitumor activity of the MEK inhibitor TAK-733 against melanoma cell lines and patient-derived tumor explants. Mol Cancer Ther. 2015 Feb;14(2):317-25.

溶解性：

Soluble in DMSO

保存条件：

-20℃

配置溶液浓度参考：

	1mg	5mg	10mg
1 mM	1.983 ml	9.916 ml	19.832 ml
5 mM	0.397 ml	1.983 ml	3.966 ml
10 mM	0.198 ml	0.992 ml	1.983 ml
50 mM	0.04 ml	0.198 ml	0.397 ml

注意：

部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。

参考文献

质检证书(COA)

输入产品批号：

如何获取质检证书(COA)?

请输入货号和一个与之匹配的批号。
例如:
批号：JS298415 货号：S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

质量

浓度

体积

分子摩尔量

计算重置